哮喘患者报告结局的最新进展
本文综述了哮喘领域患者报告结局测量工具(PROMs)的临床应用与研究进展,讨论了如何批判性评价PROMs,并介绍了评估哮喘控制与发作风险的新工具,指出其在改善哮喘管理中的真实世界证据仍有限。
要点
- PROMs是哮喘评估的基础工具,可标准化量化症状、用药、发作及功能损害。
- 管理指南已纳入PROMs评估哮喘控制,但改善哮喘照护的真实世界证据有限。
- 新工具Asthma Impairment and Risk Questionnaire与CompEx可能改善风险识别与试验效率。
核心结论
- PROMs是哮喘评估的基本组成部分,新工具可能改善不良结局风险患者的识别并缩短药物研发周期,但需紧急研究验证其临床实用性。
研究设计与样本
- 本文为综述,检索并汇总了哮喘患者报告结局测量工具(PROMs)在临床实践与研究中的应用证据。
主要发现
- 哮喘特异性PROMs已开发用于测量症状、用药、发作及情绪和身体功能损害等多种疾病特征。
- 部分PROMs包含肺功能检查或扩展问题以重叠鼻炎症状。
- PROMs在表征控制不佳的哮喘患者时可能不够准确,与发作风险的相关性仅为中等。
- 新PROMs包括Asthma Impairment and Risk Questionnaire(评估哮喘控制并纳入发作风险与损害领域)和CompEx(结合每日日记报告与发作事件的复合工具,作为干预试验的早期疗效信号)。
临床怎么用
- 临床中可使用PROMs标准化评估哮喘控制、症状负担及功能损害,但需注意其在控制不佳患者中的准确性有限。
- 新工具如Asthma Impairment and Risk Questionnaire可用于识别发作风险较高的患者,CompEx可作为试验早期疗效信号。
局限性
- PROMs改善哮喘照护的真实世界证据仍有限。
- PROMs在控制不佳的哮喘患者中准确性可能较低,与发作风险相关性仅为中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
TOPIC IMPORTANCE: Patient-reported outcomes (PROs) are information provided by patients on their condition, function, well-being, or experience. Instruments to quantify PROs, called patient-reported outcome measures (PROMs), allow standardized assessment of a unique dimension of health that cannot be measured physically. Herein, we discuss how to appraise PROMs critically and provide an update on their use in asthma clinical practice and research. REVIEW FINDINGS: Asthma-specific PROMs have been developed to measure a wide array of disease characteristics, including symptoms, medication use, exacerbations, and impairments to emotional and physical function. Some PROMs also include spirometry or expand questions to overlap with rhinitis symptoms. Use of PROMs to understand asthma control is included in management guidelines, yet real-world evidence of their effectiveness in improving asthma care remains limited. These instruments may be less accurate in characterizing patients with poorly controlled asthma and have modest correlation with exacerbation risk. Two new PROMs are highlighted, the Asthma Impairment and Risk Questionnaire as an instrument to assess asthma control that incorporates domains related to exacerbation risk and impairment, and the CompEx as a composite of daily diary reporting combined with exacerbation events as an early efficacy signal for interventional trials. SUMMARY: PROMs are fundamental to asthma assessment. Novel instruments may improve the detection of patients at risk for poor outcomes and shorten the drug discovery pipeline. However, urgent research is needed to understand their practical utility in clinical settings.
引用
- Wu, Diamant, Hanania, et al. An Update on Patient-Reported Outcomes in Asthma. Chest. 2024. PMID: 38365175. doi:10.1016/j.chest.2024.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。